Preemptive surgery

Surgery

Volumn 140, Issue 1, 2006, Pages 1-5

  McAuliffe, Priscilla F ^a   Cance, William G ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; RPI 1; TAMOXIFEN; UNCLASSIFIED DRUG;

BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; COLON CANCER; COLON POLYPOSIS; COLON RESECTION; COLONOSCOPY; ENDOMETRIUM CANCER; FAMILY HISTORY; GENE; GENE MUTATION; HUMAN; HYSTERECTOMY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MLH1 GENE; MLH2 GENE; MORBIDITY; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OSTEOPOROSIS; OVARIECTOMY; OVARY CANCER; PERITONEUM CANCER; PREEMPTIVE SURGERY; PREGNANCY; PRIORITY JOURNAL; PROCTOCOLECTOMY; RET ONCOGENE; REVIEW; SIPPLE SYNDROME; STOMACH CANCER; SURGICAL TECHNIQUE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR SUPPRESSOR GENE; UNSPECIFIED SIDE EFFECT;

ADENOMATOUS POLYPOSIS COLI; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASMS; OVARIAN NEOPLASMS; STOMACH NEOPLASMS; THYROID NEOPLASMS;

EID: 33745960630     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.01.009     Document Type: Review

References (32)

1. Eng C., Hampel H., and de la Chapelle A. Genetic testing for cancer predisposition. Annu Rev Med 52 (2001) 371-400
2. Brennan M.F. Pre-emptive surgery and increasing demands for technical perfection. Br J Surg 90 (2003) 3-4
3. Brandi M.L., Gagel R.F., Angeli A., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86 (2001) 5658-5671
4. Wells Jr. S.A., and Skinner M.A. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Exp Clin Endocrinol Diabetes 106 (1998) 29-34
5. Szinnai G., Meier C., Komminoth P., and Zumsteg U.W. Review of multiple endocrine neoplasia type 2A in children. therapeutic results of early thyroidectomy and prognostic value of codon analysis. Pediatrics 111 (2003) E132-E139
6. Cance W.G., and Wells Jr. S.A. Multiple endocrine neoplasia. Type IIa. Curr Probl Surg 22 (1985) 1-56
7. Quayle F.J., Benveniste R., DeBenedetti M.K., et al. Hereditary medullary thyroid carcinoma in patients greater than 50 years old. Surgery 136 (2004) 1116-1121
8. Skinner M.A., Norton J.A., Moley J.F., et al. Heterotopic autotransplantation of parathyroid tissue in children undergoing total thyroidectomy. J Pediatr Surg 32 (1997) 510-513
9. Matloff E.T., Shappell H., Brierley K., et al. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 18 (2000) 2484-2492
10. Hartmann L.C., Degnim A., and Schaid D.J. Prophylactic mastectomy for BRCA1/2 carriers. progress and more questions. J Clin Oncol 22 (2004) 981-983
11. Meijers-Heijboer E.J., Verhoog L.C., Brekelmans C.T., et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355 (2000) 2015-2020
12. van Geel A.N. Prophylactic mastectomy. the Rotterdam experience. Breast 12 (2003) 357-361
13. Breast Cancer Linkage Consortium. Pathology of familial breast cancer. differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349 (1997) 1505-1510
14. Meijers-Heijboer H., van Geel B., van Putten W.L., et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345 (2001) 159-164
15. Tilanus-Linthorst M.M., Obdeijn I.M., Bartels K.C., et al. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63 (2000) 53-60
16. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. the PROSE Study Group. J Clin Oncol 22 (2004) 1055-1062
17. Wood W.C. The future of surgery in the treatment of breast cancer. Breast 12 (2003) 472-474
18. Lodder L.N., Frets P.G., Trijsburg R.W., et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2. emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73 (2002) 97-112
19. Haber D. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations. N Engl J Med 346 (2002) 1660-1662
20. Kauff N.D., Satagopan J.M., Robson M.E., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346 (2002) 1609-1615
21. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346 (2002) 1616-1622
22. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 (2000) 829-834
23. King J.E., Dozois R.R., Lindor N.M., and Ahlquist D.A. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 75 (2000) 57-67
24. Vasen H.F., van Duijvendijk P., Buskens E., et al. Decision analysis in the surgical treatment of patients with familial adenomatous polyposis. a Dutch-Scandinavian collaborative study including 659 patients. Gut 49 (2001) 231-235
25. Bjork J., Akerbrant H., Iselius L., et al. Outcome of primary and secondary ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 44 (2001) 984-992
26. Thompson-Fawcett M.W., Marcus V.A., Redston M., et al. Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis. Dis Colon Rectum 44 (2001) 347-353
27. Olsen K.O., Juul S., Bulow S., et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 90 (2003) 227-231
28. Syngal S., Weeks J.C., Schrag D., et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 129 (1998) 787-796
29. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
30. Huntsman D.G., Carneiro F., Lewis F.R., et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344 (2001) 1904-1909
31. Is prevention really better than cure?. Lancet Oncol 3 (2002) 645
32. Wells S.A., and Nevins J.R. Evolving strategies for targeted cancer therapy-past, present, and future. J Natl Cancer Inst 96 (2004) 980-981